Parathyroid hormone (PTH) has been associated with anemia only in dialysis patients with severe hyperparathyroidism. Whether an association between PTH and hemoglobin also exists in patients with chronic kidney disease not on dialysis (CKD-patients) is still unclear. In this study we evaluated the association between PTH and hemoglobin in CKD-patients without severe secondary hyperparathyroidism.
In recent years, roles of the immune system in immune surveillance of cancer have been explored using a variety of approaches. The roles of the adaptive immune system have been a major emphasis, but increasing evidence supports a role for innate immune effector cells such as natural killer (NK) cells in tumor surveillance. Here, we discuss some of the evidence for roles in tumor surveillance of innate immune cells. In particular, we focus on NK cells and other immune cells that express germline-encoded receptors, often labeled NK receptors. The impact of these receptors and the cells that express them on tumor suppression is summarized. We discuss in detail some of the pathways and events in tumor cells that induce or upregulate cell-surface expression of the ligands for these receptors, and the logic of how those pathways serve to identify malignant, or potentially malignant cells. How tumors often evade tumor suppression mediated by innate killer cells is another major subject of the review. We end with a discussion on some of the implications of the various findings with respect to possible therapeutic approaches.
Perturbations in cerebral blood volume (CBV), blood flow (CBF), and metabolic rate of oxygen (CMRO2) lead to associated changes in tissue concentrations of oxy- and deoxy-hemoglobin (ΔO and ΔD), which can be measured by near-infrared spectroscopy (NIRS). A novel hemodynamic model has been introduced to relate physiological perturbations and measured quantities. We seek to use this model to determine functional traces of cbv(t) and cbf(t) - cmro2(t) from time-varying NIRS data, and cerebrovascular physiological parameters from oscillatory NIRS data (lowercase letters denote the relative changes in CBV, CBF, and CMRO2 with respect to baseline). Such a practical implementation of a quantitative hemodynamic model is an important step toward the clinical translation of NIRS.
As breast magnetic resonance imaging (MRI) use grows, benchmark performance parameters are needed for auditing and quality assurance purposes. We describe the variation in breast MRI abnormal interpretation rates (AIRs) by clinical indication among a large sample of US community practices.
During the last 40 years, the mass of the artificial objects in orbit increased quite steadily at the rate of about 145 metric tons annually, leading to about 7000 metric tons. Most of the cross-sectional area and mass (97% in low Earth orbit) is concentrated in about 4500 intact abandoned objects plus a further 1000 operational spacecraft. Analyses have shown that the most effective mitigation strategy should focus on the disposal of objects with larger cross-sectional area and mass from densely populated orbits. Recent NASA results have shown that the worldwide adoption of mitigation measures in conjunction with active yearly removal of approximately 0.2-0.5% of the abandoned objects would stabilize the debris population. Targets would have typical masses between 500 and 1000 kg in the case of spacecraft, and of more than 1000 kg for rocket upper stages. In the case of Cosmos-3M second stages, more than one object is located nearly in the same orbital plane. This provides the opportunity of multi-removal missions, more suitable for yearly removal rate and cost reduction needs. This paper deals with the feasibility study of a mission for the active removal of large abandoned objects in low Earth orbit. In particular, a mission is studied in which the removal of two Cosmos-3M second stages, that are numerous in low Earth orbit, is considered. The removal system relies on a Chaser spacecraft which performs rendezvous maneuvers with the two targets. The first Cosmos-3M stage is captured and an autonomous de-orbiting kit, carried by the Chaser, is attached to it. The de-orbiting kit includes a Hybrid Propulsion Module, which is remotely ignited to perform stage disposal and controlled reentry after Chaser separation. Then, the second Cosmos-3M stage is captured and, in this case, the primary propulsion system of the Chaser is used for the disposal of the mated configuration. Critical mission aspects and related technologies are investigated at a preliminary level. In particular, an innovative electro-adhesive system for target capture, a mechanical system for the hard docking with the target and a hybrid propulsion system suitable for rendezvous, de-orbiting and controlled reentry operations are analyzed. This is performed on the basis of a preliminary mission profile, in which suitable rendezvous and disposal strategies have been considered and investigated by numerical analysis. A preliminary system mass budget is also performed, showing that the Chaser overall mass is about 1350 kg, including a primary propulsion system of about 300 kg and a de-orbiting kit with a mass of about 200 kg. This system is suitable to be launched with VEGA, actually the cheapest European space launcher